Detailansicht

Wissensnetz

Person

Patrick Oeckl (1979-)

Name	Patrick Oeckl
Zeit	1979- (Lebensdaten)
Ort	Friedrichshafen (Geburtsort) Deutschland
Geschlecht	männlich
Akademischer Grad bzw. Titel	Dr. biol. hum. Dipl. oec. troph.
Variante	Patrick Öckl
Weitere Angaben	Ulm, Univ., Tag der Promotion: 22.07.2013
Quelle	Vorlage
Datensatztyp	Person
GND-Nummer	104125945X
Datensatz-ID	104125945X
Beteiligt an alle anzeigen Serum β-synuclein, neurofilament light chain and glial fibrillary acidic protein as prognostic biomarkers in moderate-to-severe acute ischemic stroke Relationship of serum beta‐synuclein with blood biomarkers and brain atrophy Visinin-like protein 1 levels in blood and CSF as emerging markers for Alzheimer’s and other neurodegenerative diseases Cerebrospinal fluid levels of proenkephalin and prodynorphin are differentially altered in Huntington’s and Parkinson’s disease Increased NF-L levels in the TDP-43G298S ALS mouse model resemble NF-L levels in ALS patients Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration Neuronal pentraxins as biomarkers of synaptic activity : from physiological functions to pathological changes in neurodegeneration Different CSF protein profiles in amyotrophic lateral sclerosis and frontotemporal dementia with C9orf72 hexanucleotide repeat expansion Importance of cerebrospinal fluid analysis in the era of McDonald 2010 criteria: a German-Austrian retrospective multicenter study in patients with a clinically isolated syndrome Proteomics in cerebrospinal fluid and spinal cord suggests UCHL1, MAP2 and GPNMB as biomarkers and underpins importance of transcriptional pathways in amyotrophic lateral sclerosis Reduction of ephrin-A5 aggravates disease progression in amyotrophic lateral sclerosis Alpha-synuclein is present in dental calculus but not altered in Parkinson’s disease patients in comparison to controls Importance of cerebrospinal fluid analysis in the era of McDonald 2010 criteria: a German–Austrian retrospective multicenter study in patients with a clinically isolated syndrome Establishment of mass spectrometric determination of the biomarkers cAMP and cGMP and investigation of potential pathogenic processes (GPR6, telomerase, microglial activation) in animal models of Parkinson´s disease

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Patrick Oeckl (1979-)

Serum β-synuclein, neurofilament light chain and glial fibrillary acidic protein as prognostic biomarkers in moderate-to-severe acute ischemic stroke

Relationship of serum beta‐synuclein with blood biomarkers and brain atrophy

Visinin-like protein 1 levels in blood and CSF as emerging markers for Alzheimer’s and other neurodegenerative diseases

Cerebrospinal fluid levels of proenkephalin and prodynorphin are differentially altered in Huntington’s and Parkinson’s disease

Increased NF-L levels in the TDP-43G298S ALS mouse model resemble NF-L levels in ALS patients

Neuronal pentraxins as biomarkers of synaptic activity: from physiological functions to pathological changes in neurodegeneration

Neuronal pentraxins as biomarkers of synaptic activity : from physiological functions to pathological changes in neurodegeneration

Different CSF protein profiles in amyotrophic lateral sclerosis and frontotemporal dementia with C9orf72 hexanucleotide repeat expansion

Importance of cerebrospinal fluid analysis in the era of McDonald 2010 criteria: a German-Austrian retrospective multicenter study in patients with a clinically isolated syndrome

Proteomics in cerebrospinal fluid and spinal cord suggests UCHL1, MAP2 and GPNMB as biomarkers and underpins importance of transcriptional pathways in amyotrophic lateral sclerosis

Reduction of ephrin-A5 aggravates disease progression in amyotrophic lateral sclerosis

Alpha-synuclein is present in dental calculus but not altered in Parkinson’s disease patients in comparison to controls

Importance of cerebrospinal fluid analysis in the era of McDonald 2010 criteria: a German–Austrian retrospective multicenter study in patients with a clinically isolated syndrome

Establishment of mass spectrometric determination of the biomarkers cAMP and cGMP and investigation of potential pathogenic processes (GPR6, telomerase, microglial activation) in animal models of Parkinson´s disease